Liraglutide (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Liraglutide" in Italian language version.

refsWebsite

Global rank Italian rank

3doi.org

2^nd place

7^th place

1agenziafarmaco.gov.it

low place

1,603^rd place

1drugs.com

399^th place

1,563^rd place

1webmd.com

1,169^th place

2,954^th place

1nih.gov

4^th place

9^th place

1nihr.ac.uk

low place

1worldcat.org

5^th place

26^th place

1fda.gov

447^th place

644^th place

1jamanetwork.com

2,650^th place

2,089^th place

1nejm.org

2,374^th place

1,283^rd place

agenziafarmaco.gov.it

farmaci.agenziafarmaco.gov.it

Farmaco | Banca Dati Farmaci dell'AIFA voce Liraglutide, su farmaci.agenziafarmaco.gov.it. URL consultato il 15 novembre 2018.

doi.org

dx.doi.org

Jiali Liu, Ling Li e Ke Deng, Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis, in The BMJ, vol. 357, 8 giugno 2017, DOI:10.1136/bmj.j2499. URL consultato il 28 novembre 2019.
(EN) Shyangdan D, Cummins E e Royle P, Liraglutide for the treatment of type 2 diabetes, in Health Technology Assessment, vol. 15, Suppl 1 Article 9, 14 giugno 2011, DOI:10.3310/hta15Suppl1/09. URL consultato il 28 novembre 2019.
(EN) Sonal Singh, Hsien-Yen Chang e Thomas M. Richards, Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus: A Population-Based Matched Case-Control Study, in JAMA Internal Medicine, vol. 173, n. 7, 8 aprile 2013, pp. 534–539, DOI:10.1001/jamainternmed.2013.2720. URL consultato il 28 novembre 2019.

drugs.com

(EN) Liraglutide Monograph for Professionals, su Drugs.com. URL consultato il 28 novembre 2019.

fda.gov

accessdata.fda.gov

These highlights do not include all the information needed to use Victoza safely and effectively. See full prescribing information for Victoza. (PDF).

jamanetwork.com

(EN) Sonal Singh, Hsien-Yen Chang e Thomas M. Richards, Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus: A Population-Based Matched Case-Control Study, in JAMA Internal Medicine, vol. 173, n. 7, 8 aprile 2013, pp. 534–539, DOI:10.1001/jamainternmed.2013.2720. URL consultato il 28 novembre 2019.

nejm.org

(EN) Amy G. Egan, Eberhard Blind, Kristina Dunder, Pieter A. de Graeff, B. Timothy Hummer, Todd Bourcier, Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment, su dx.doi.org, 26 febbraio 2014. URL consultato il 28 novembre 2019.

nih.gov

ncbi.nlm.nih.gov

Jiali Liu, Ling Li e Ke Deng, Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis, in The BMJ, vol. 357, 8 giugno 2017, DOI:10.1136/bmj.j2499. URL consultato il 28 novembre 2019.

nihr.ac.uk

journalslibrary.nihr.ac.uk

(EN) Shyangdan D, Cummins E e Royle P, Liraglutide for the treatment of type 2 diabetes, in Health Technology Assessment, vol. 15, Suppl 1 Article 9, 14 giugno 2011, DOI:10.3310/hta15Suppl1/09. URL consultato il 28 novembre 2019.

webmd.com

(EN) Daniel J. DeNoon, New Diabetes Drug Liraglutide Works, su WebMD. URL consultato il 28 novembre 2019.

worldcat.org

Furlanut, Mario., Farmacologia : principi e applicazioni, IIª ed., Piccin, 2013, p. 362, ISBN 978-88-299-2165-2, OCLC 849109280. URL consultato il 23 novembre 2018.